Case Control Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Sep 28, 2017; 23(36): 6674-6684
Published online Sep 28, 2017. doi: 10.3748/wjg.v23.i36.6674
Table 1 Distribution of hepatocellular carcinoma patients, hepatitis B/hepatitis C -positive individuals and healthy subjects according to socio-demographic and clinical characteristics n (%)
CharacteristicsHCC groupHBV/HCV groupHealthy group
Sex
Men166 (86.5)141 (84.4)166 (86.5)
Women26 (13.5)26 (15.6)26 (13.5)
Age (yr)
< 5585 (44.3)85 (50.9)96 (50.0)
55-5960 (31.3)19 (11.4)35 (18.2)
≥ 6047 (24.5)63 (37.7)61 (31.8)
Hepatitis infection
None0 (0.0)0 (0.0)192 (100.0)
HBV+ and HCV-74 (38.5)74 (44.3)0 (0.0)
HBV- and HCV+109 (56.8)88 (52.7)0 (0.0)
HBV+ and HCV+9 (4.7)5 (3.0)0 (0.0)
Years of orthotopic liver transplantation or resection
1991-199527 (14.1)
1996-200060 (31.3)
2001-2006102 (54.7)
Number of nodes
1110 (57.3)
≥ 272 (37.5)
Unknown10 (5.2)
Maximal dimension of nodes (cm)
≤ 279 (41.2)
2.1 to ≤ 367 (34.9)
> 337 (19.3)
Unknown9 (4.7)